HYBRIGENICS Financials
| 3HB Stock | EUR 0.01 0.0002 2.82% |
HYBRIGENICS |
Understanding current and past HYBRIGENICS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of HYBRIGENICS's financial statements are interrelated, with each one affecting the others. For example, an increase in HYBRIGENICS's assets may result in an increase in income on the income statement.
Please note, the presentation of HYBRIGENICS's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HYBRIGENICS's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of HYBRIGENICS's management manipulating its earnings.
HYBRIGENICS Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HYBRIGENICS's current stock value. Our valuation model uses many indicators to compare HYBRIGENICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HYBRIGENICS competition to find correlations between indicators driving HYBRIGENICS's intrinsic value. More Info.HYBRIGENICS A is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for HYBRIGENICS A is about 11,989,945 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HYBRIGENICS's earnings, one of the primary drivers of an investment's value.HYBRIGENICS A Systematic Risk
HYBRIGENICS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. HYBRIGENICS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on HYBRIGENICS A correlated with the market. If Beta is less than 0 HYBRIGENICS generally moves in the opposite direction as compared to the market. If HYBRIGENICS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one HYBRIGENICS A is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of HYBRIGENICS is generally in the same direction as the market. If Beta > 1 HYBRIGENICS moves generally in the same direction as, but more than the movement of the benchmark.
HYBRIGENICS December 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of HYBRIGENICS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of HYBRIGENICS A . We use our internally-developed statistical techniques to arrive at the intrinsic value of HYBRIGENICS A based on widely used predictive technical indicators. In general, we focus on analyzing HYBRIGENICS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build HYBRIGENICS's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 38.01 | |||
| Value At Risk | (9.30) | |||
| Potential Upside | 9.68 |
Complementary Tools for HYBRIGENICS Stock analysis
When running HYBRIGENICS's price analysis, check to measure HYBRIGENICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HYBRIGENICS is operating at the current time. Most of HYBRIGENICS's value examination focuses on studying past and present price action to predict the probability of HYBRIGENICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HYBRIGENICS's price. Additionally, you may evaluate how the addition of HYBRIGENICS to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stocks Directory Find actively traded stocks across global markets |